Neurocognitive basis of insight in schizophrenia

	Tweet

People with schizophrenia have been categorised into three groups: those with full insight (aware, correct attributers); those aware of being unwell, but who misattributed their symptoms (aware, incorrect attributers); and those unaware of being ill (unaware).

Cluster analysis of ‘awareness of illness’ and ‘relabelling of symptoms’ scores on the Schedule for the Assessment of Insight confirmed three distinct subgroups. The unaware group were impaired on executive and memory tests, whereas those in the aware, misattributing group were cognitively intact.

INTRODUCTION
Lack of insight in psychiatric illness may comprise multiple processes such as self-awareness, attribution of illness, social consequences of illness and perceived need for treatment (David, 1990; Amador et al, 1994; Morgan & David, 2004), some of which may be amenable to treatment. However, poor insight may result from cognitive impairment (for review, see Aleman et al, 2006). If lack of insight is underpinned by cognitive impairment, then it may require a therapeutic approach which is different from that currently offered (Henry & Ghaemi, 2004). Flashman & Roth (2004) proposed a classification of insight that divided patients into three groups: those with full insight (aware, correct attributers); those aware of being unwell, but who misattributed their symptoms (aware, incorrect attributers); and those unaware of being ill (unaware). These authors suggested that unawareness of illness was caused by brain dysfunction.

If true, this implies that the aware, misattributing group might be cognitively intact, and therefore might be helped by psychoeducation or psychotherapy. We predicted that cluster analysis would yield three groups that would be consistent with this model. In addition, we tested the hypothesis that unawareness would be associated with cognitive impairment, whereas cognitive function would be intact in those who misattributed illness.

Findings support an association between unawareness of illness and executive dysfunction, and highlight the separation of symptom misattribution from unawareness of illness [more...]

British Journal of Psychiatry, 06/01/07

RELATED STORIES:
CAMH study suggests increased risk of schizophrenia in heavy methamphetamine users   Brain development goes off track as vulnerable individuals develop schizophrenia   Study Compares Traits of Autism, Schizophrenia   Substance abuse, schizophrenia and risk of violence   Children at Risk for Schizophrenia Show Disordered Brain Networks   New genetic association with schizophrenia found by researchers   Discovery of new gene mutation in schizophrenia offers a new target for drug therapies   Some Symptoms of Schizophrenia Hard to Detect, Treat   Patients with Schizophrenia More Likely to Have Medical Complications   Persistent Negative Symptoms in Schizophrenia: An Overview   Altered Brain Activity in Schizophrenia May Direct Focus on Self   Knowing how ketamine impairs brain circuitry may lead to new therapies for schizophrenia   Diet And Schizophrenia: The Link Is More Important Than You Think   Hopkins researchers discover new link to schizophrenia   Can fish oil help guard against schizophrenia?

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]